Cryopreservation of islets adds great flexibility to clinical islet transplant programs. Methods of islet cryopreservation have traditionally utilized permeating cryoprotectants contained within isotonic solutions without specifically addressing issues of ionic balances, buffering capacity, or oxygen free radicals that occur during hypothermic stresses. These factors may become significant issues during low-temperature storage and during the freezing and thawing process. Since its development in the early 1980s, the University of Wisconsin (UW) organ preservation solution has become the standard vascular flush and preservation solution. Recently, Hypothermosol preservation solution (HTS) was developed as a hypothermic blood substitute. The unique characteristics and composition of these preservation solutions may be important when developing solutions specific for the cryopreservation of cells and tissues. It was the aim of this study to evaluate these two hypothermic preservation solutions as the media used in cryopreservation of islets. Groups of canine islets [5000 islet equivalents (IE)/group] were cryopreserved using the standard protocol of stepwise addition of dimethyl sulfoxide (DMSO) to 2 M, controlled nucleation, slow cooling (0.25°C/min), and rapid thawing (200°C/min). The cryopreservation solutions were made with 1) UW solution, 2) HTS solution, or 3) Medium 199 solution with 10% fetal calf serum (FCS). Additional control groups included islets cryopreserved using 4) HTS, 5) UW solution, and 6) Medium 199 alone, without DMSO. Recovery of islets immediately following thawing was equivalent between the groups with the exception of the islets cryopreserved without DMSO (groups 4-6, p < 0.05). After 48 h of postcryopreservation tissue culture, islet recovery was highest in the groups frozen with UW and HTS (mean ± SEM) (79.8 ± 1.9% and 82.5 ± 1.5%, p < 0.05 vs. group 3, 69.1 ± 3.3%, p < 0.05, ANOVA). Less than 15% of the islets were recovered when they were cryopreserved without the cryoprotectant DMSO (groups 4-6). Functional viability was assessed by measuring the glucose-stimulated insulin secretion during static incubation after 48-h culture. The stimulation indexes were 4.6 ± 1.0, 4.2 ± 0.8, 3.6 ± 1.2, 0.6 ± 0.5, and 0.4 ± 0.2 for islets in groups 1-5, respectively. This study demonstrates that postcryopreservation survival can be improved using intracellular-based preservation solutions, including UW or HTS, in conjunction with DMSO. 583 584 LAKEY ET AL.
INTRODUCTION
fective low-temperature storage also provides time for sterility and viability testing of the islet preparation (31) and for the development of donor-specific tolerance Clinical islet transplants have been used to restore euglycemia in type I insulin-dependent diabetic patients (5, 6, 11) . The ability to select preparations of islets from a pool of preserved islets provides increased flexibility (7, 33) . Inconsistencies in the ability to isolate sufficient numbers of islets from the cadaveric organ donor pan-and an ability to select specific preparations of islets based on tissue matching. However, preservation of islet creas has limited transplant success (32, 33) . One approach that has led to successful insulin withdrawal in tissue through cryopreservation results in a loss of islet mass and subsequent reduction in islet function some clinical islet transplant programs is through providing an increased transplantable mass of islets by us- (16, 21, 25) . If low-temperature banking of islets through cryopreservation is to realize its full potential, methods ing islets from multiple donor pancreases (32, 34) . In selected clinical islet transplants, cryopreserved human to cryopreserve islets must be improved. Current methods of islet cryopreservation utilize per-islets have been used to supplement the islet mass. Ef- that have been specifically developed for hypothermic preservation. It was the aim of this study was to evaluate hypothermic organ preservation solutions, UW and an early version of the Hypothermosol solution, as the meaccordance with the recommendations of the Canadian dia used in the cryopreservation of isolated canine islets.
Council on Animal Care and in consultation with a veterinarian. Pancreatic islets were isolated from mongrel MATERIALS AND METHODS dogs using the established protocols of intraductal deliv-Solutions and Reagents ery of enzyme (Liberase-CI) via the main pancreatic duct, controlled mechanical dissociation, and discontinu-Cell culture reagents and solutions for the isolation and ous Euro-Ficoll purification as previously described cryopreservation of the islets including HBSS, FCS, new- (1, 2, 10, 22, 24, 30, 34) . Purified islets were quantified usborn calf serum (NCS), Medium 199 solution, and CMRL ing defined protocols (13,23) and cultured overnight at tissue culture solution were purchased from Gibco (Life 22°C in CMRL tissue culture media, supplemented with Technologies). The enzyme used to isolate the islets, Lib-10% FCS and antibiotics (100 U/ml penicillin and 100 erase-CI enzyme, was purchased from Roche-Boehringer µg/ml streptomycin). Culture occurred prior to separa-Mannheim Inc. UW solution (Viaspan) was purchased tion into the experimental groups and islets were also from Dupont Pharma (Mississauga, ON). Hypothermosol quantified in duplicate immediately prior to cryopresersolution was provided as part of a collaboration with Allevation. gheny Medical School, Pittsburgh, PA. Other chemicals and reagents were obtained from Sigma Chemicals (St.
Islet Cryopreservation Louis, MO), or as otherwise indicated.
Isolated islets from all experimental groups were Islet Isolation cryopreserved using the established protocols of Rajotte et al. (19,20) ( Fig. 1) . Briefly, the cryoprotectant DMSO All experiments were performed using islets isolated from pancreases of mongrel dogs that were cared for in was added in a stepwise manner to a final concentration of 2 M using stock cryoprotectant solutions that were mass using dithizone staining in accordance to criteria established at the 1989 International Workshop on Islet prepared in UW solution, HTS solution, or the standard media Medium 199 solution supplemented with 10% Assessment (23) . The diameter of each islet was sized and categorized using a graticule in the eyepiece of a FCS and antibiotics. The groups of islets cryopreserved in UW solution or in HTS solution had cryoprotectant dissecting microscope. Islet mass was quantified and then converted to the standard unit of measurement of added at 4°C. Tubes from the Medium 199 group were cooled to 4°C after the final equilibration period. Tubes islets, islet equivalent (IE). The percent recovery was also assessed after 48 h of postcryopreservation tissue from all groups were then cooled to −7.4°C before controlled nucleation using a supercooled metal rod. Sam-culture by dithizone staining of aliquots.
To assess in vitro viability of the islets, both pre-ples were held at −7.4°C for 15 min to allow dissipation of all heat produced by the latent heat of fusion. Tubes and post cryopreservation, a known aliquot of islets was incubated in a RPMI solution that was supplemented were then slowly cooled at 0.25°C/min to −40°C before plunging into liquid nitrogen (−196°C) for low-tempera-with low (2.8 mM) then high (20 mM) glucose solution for a period of 2 h in a 37°C incubator (12). The super-ture storage.
Tubes containing islets from each experimental group natant was removed and assessed for insulin content using double antibody radioimmunoassay with comparison were rapidly thawed (200°C/min) in a 37°C water bath and the DMSO removed using a serial dilution follow-to human insulin standards (Cost-a-Count kit, PDC, Los Angeles, CA) (15). The functional viability of the islets ing incubation in 0.75 M sucrose using defined protocols (12,21). Following removal of samples to assess islet was expressed as insulin release per islet equivalent. The stimulation index was calculated by dividing the insulin recovery, remaining frozen/thawed islets were placed in petri dishes containing CMRL tissue culture media, sup-output from the high glucose stimulatory phase by insulin secretion during low basal incubation. plemented with 25 mM HEPES, 10% FCS, and antibiotics, and cultured at 37°C in a humidified atmosphere of Statistical Analysis 95% air 5% CO 2 .
Results are expressed as mean ± SEM. Differences Recovery/Viability Assessment between the experimental groups were analyzed by Student's paired t-tests and ANOVA using customized sta-Duplicate aliquots of islets from each experiment were assessed for the recovery by quantifying the islet tistical software. The differences between the experi-mental groups were considered statistically significant at 37°C had an elevated basal insulin secretion when compared with nonfrozen control during low-glucose when p < 0.05.
(2.8 mM) incubation (Table 3) . During stimulation with RESULTS RPMI solution containing 20 mM glucose (high glu-Islet Recovery Following Cryopreservation cose), islets from all groups cryopreserved with DMSO elicited a stimulated insulin response of between 5.0 and The recovery of canine islets from a series of six con-5.9 µU insulin/IE/h compared with 8.4 ± 0.2 in the nonsecutive experiments following cryopreservation and 48frozen control group of islets. Islets cryopreserved withh postcryopreservation tissue culture are presented in out DMSO did not respond to the high glucose by in- Table 2 . Islets cryopreserved in UW solution with 2 M creasing insulin output. DMSO had a recovery of 84.4 ± 2.6%. This is consistent
The stimulation index, a ratio of the insulin secreted with previous published recoveries of canine islet prepaduring high-glucose stimulation over the insulin output rations following cryopreservation and low-temperature during low basal levels, was 4.1 ± 0.3 for control nonstorage (11,30). The recovery of islets cryopreserved in frozen group of islets (Table 3 ). Islets cryopreserved in the presence of DMSO using HTS and Medium 199 was DMSO prepared in UW solution had a SI of 4.6 ± 1.0 similar to the recovery seen when UW solution was used that was equivalent to the response observed in islets (86.2 ± 2.3% and 79.1 ± 2.5%, respectively, p = NS).
cryopreserved in HTS solution (p = NS). Control group This compares with an 84.6 ± 3.5% recovery of control of islets cryopreserved in the standard solution of Menoncryopreserved islets that were placed in tissue culdium 199 had a stimulation index of 4.1 ± 0.3 (p = NS). ture at 37°C immediately following the islet isolation Islets cryopreserved in UW or HTS solution without the cultured for 48 h (p = NS).
cryoprotectant DMSO did not respond in vitro during Islets cryopreserved in the presence of DMSO in Melow-or high-glucose stimulation (p < 0.05). dium 199 and then cultured for 48 h at 37°C showed a 69.1 ± 3.3% recovery, which is significantly different DISCUSSION from islets preserved in the presence of UW or HTS Recovery of functionally viable islets following cryo-(79.8 ± 1.9% and 82.5 ± 1.5%, respectively, p < 0.05).
preservation is a key prerequisite if cryopreserved islets Islets frozen in the absence of DMSO showed recovery are to be effectively utilized in clinical islet transplantabelow 15% after 48 h culture in all groups (p = NS, betion. To date, only a limited number of clinical islet tween groups without DMSO).
transplants have used cryopreserved islets to increase the Static Incubation total transplanted islet mass. The quality and condition of islets prior to cryopreservation significantly impact In vitro functional viability of the cultured nonfrozen their recovery and function following thawing and reislets and cryopreserved canine islets frozen using moval of the cryoprotectant. DMSO, prepared in UW, HTS, and supplemented Me-There are several advantages in developing a bank of dium 199 is illustrated in Table 3 . Islets that had been cryopreserved islets, including the ability to select prepcryopreserved and then cultured for a period of 48 h arations of islets based upon ABO or HLA phenotypes. Thawing a sample tube of cryopreserved islets from a preparation of banked islets permits assessment of the cur during the cryopreservation process (14). These sim- ulated responses of islet cells to different osmotic envi-cells. These solutions help to minimize hypothermically induced swelling that minimizes extreme volume excur-ronments make important predictions about key factors involved in cryopreservation, including cryoprotectant sions in islet cells during freezing and thawing, thereby decreasing osmotic injury (28) . The Na + /K + and the Ca 2+ / permeation, cellular volume changes, and incidence of intracellular ice formation.
Mg 2+ ratios in hypothermic preservation solutions are adjusted to restrict passive diffusion of these ions at low Cryopreservation of islets using solutions specifically derived for cells and tissues at hypothermic temperatures temperatures when ionic pumps are inactivated (28) . This may also help to minimize swelling associated with have many theoretical advantages over the standard tissue culture solutions. In keeping the cryoprotectant con-hypothermia and may help recovery of cells after thawing. The buffer used in hypothermic preservation solu-stant through all experimental groups, we can assess the potential benefits of one solution over another. In these tions is able to work at low temperatures, which will prevent intracellular acidosis during freezing and thaw-experiments, we observed that the recovery of islets immediately following the cryopreservation process was ing of cells. Intracellular preservation solutions also contain compounds that prevent injury from free radicals equivalent between the groups of islets cryopreserved in either UW, HTS, or the control group in Medium 199 (28) . Mannitol is a hydroxy radical scavenger and glutathione is also a hydroxy radical scavenger and is also an solution. However, after a period of tissue culture, where the damaged islets disaggregate and die, we observed antioxidant. Glutathione is also a cofactor for glutathione peroxidase, which breaks down lipid peroxides and that the groups of islets cryopreserved in either UW or HTS solution had significantly higher islet recovery hydrogen peroxide (28) . One potential benefit for the groups using UW and (p < 0.05). The control groups of islets cryopreserved without DMSO had little islet recovery and no function HTS solutions is that islets were maintained at hypothermic temperatures throughout the cryopreservation pro-(p < 0.05). This confirmed that the nonpermeating cryoprotective agents in UW or HTS solution were not able cess. The standard islet cryopreservation protocol involves adding DMSO in a stepwise manner at room to confer adequate protection from the damaging effects of cryopreservation on islet cells. This finding contra-temperature. Only when the concentration of DMSO has equilibrated at 2 M is temperature reduced to 4°C. This dicts the results of Baust et al. (3) , which suggest that more studies should be performed using intracellular protocol is used because cryoprotectant permeation is temperature dependent; reducing the temperature will preservation solutions in the cryopreservation of various other cell types.
slow the permeation of DMSO into the islets. The observation of improved survival of islets when cryoprotec-Hypothermic organ preservation solutions are designed to prevent damage to tissues caused by exposure tant is added at 4°C may suggest that the toxic effects of DMSO are lower when temperature is reduced. This to the hypothermic and ischemic stresses associated with organ storage (26) . The properties that make preserva-may be due to a lower concentration of DMSO in the cells, due to lower permeability, rather than actually tion solutions effective for low-temperature organ storage may also augment the recovery of cryopreserved having lower toxicity. Future experimental studies will 588 LAKEY ET AL. 
